Andres Y. Maldonado
Stock Analyst at HC Wainwright & Co.
(4.47)
# 325
Out of 5,042 analysts
17
Total ratings
62.5%
Success rate
23.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Y. Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRBP Corbus Pharmaceuticals Holdings | Reiterates: Buy | $40 | $16.88 | +136.97% | 2 | Oct 20, 2025 | |
| SNDX Syndax Pharmaceuticals | Assumes: Buy | $40 | $13.53 | +195.64% | 1 | Oct 16, 2025 | |
| MRUS Merus | Downgrades: Neutral | $135 → $97 | $94.88 | +2.23% | 1 | Sep 30, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $23 | $5.40 | +325.93% | 1 | Sep 29, 2025 | |
| MNPR Monopar Therapeutics | Maintains: Buy | $70 → $105 | $81.57 | +28.72% | 2 | Sep 29, 2025 | |
| SRRK Scholar Rock Holding | Maintains: Buy | $50 → $44 | $29.68 | +48.25% | 1 | Sep 23, 2025 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $43.67 | +71.74% | 3 | Sep 15, 2025 | |
| ENGN enGene Holdings | Reiterates: Buy | $25 | $8.20 | +204.88% | 2 | Sep 12, 2025 | |
| IBRX ImmunityBio | Reiterates: Buy | $8 | $2.47 | +223.89% | 1 | Sep 10, 2025 | |
| IMAB I-Mab | Reiterates: Buy | $7 | $4.22 | +65.88% | 1 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $5.86 | +275.43% | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $15.04 | +32.98% | 1 | Aug 8, 2025 |
Corbus Pharmaceuticals Holdings
Oct 20, 2025
Reiterates: Buy
Price Target: $40
Current: $16.88
Upside: +136.97%
Syndax Pharmaceuticals
Oct 16, 2025
Assumes: Buy
Price Target: $40
Current: $13.53
Upside: +195.64%
Merus
Sep 30, 2025
Downgrades: Neutral
Price Target: $135 → $97
Current: $94.88
Upside: +2.23%
Candel Therapeutics
Sep 29, 2025
Reiterates: Buy
Price Target: $23
Current: $5.40
Upside: +325.93%
Monopar Therapeutics
Sep 29, 2025
Maintains: Buy
Price Target: $70 → $105
Current: $81.57
Upside: +28.72%
Scholar Rock Holding
Sep 23, 2025
Maintains: Buy
Price Target: $50 → $44
Current: $29.68
Upside: +48.25%
CG Oncology
Sep 15, 2025
Reiterates: Buy
Price Target: $75
Current: $43.67
Upside: +71.74%
enGene Holdings
Sep 12, 2025
Reiterates: Buy
Price Target: $25
Current: $8.20
Upside: +204.88%
ImmunityBio
Sep 10, 2025
Reiterates: Buy
Price Target: $8
Current: $2.47
Upside: +223.89%
I-Mab
Aug 21, 2025
Reiterates: Buy
Price Target: $7
Current: $4.22
Upside: +65.88%
Aug 13, 2025
Reiterates: Buy
Price Target: $22
Current: $5.86
Upside: +275.43%
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $20
Current: $15.04
Upside: +32.98%